# Eribulin Mesylate

NDC: 71731-4171
Generic name: Eribulin Mesylate
Labeler / Manufacturer: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20250304

FDA application: ANDA218743

## Active ingredients

- ERIBULIN MESYLATE: .5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71731-4171"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71731-4171
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a81f3e9-ac52-4f98-bf62-da7974d012b3